Sarah Moberley
Overview
Explore the profile of Sarah Moberley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Howard Z, Carlson S, Moberley S, Butler M, Dalton C
Commun Dis Intell (2018)
. 2022 Jul;
46.
PMID: 35860873
No abstract available.
2.
Moberley S, Carlson S, Durrheim D, Dalton C
Commun Dis Intell (2018)
. 2019 Jul;
43.
PMID: 31315314
Flutracking participation continued to grow, with a total of 33,947 participants in 2017 (a 9.5% increase from 2016). The majority of participants completed their survey within 24 hours of the...
3.
Cashman P, Moberley S, Durrheim D
Vaccine
. 2018 Mar;
37(30):3946.
PMID: 29526373
No abstract available.
4.
Licciardi P, Hoe E, Toh Z, Balloch A, Moberley S, Binks P, et al.
Clin Transl Immunology
. 2017 Nov;
6(10):e158.
PMID: 29114387
Indigenous Australians experience one of the highest rates of pneumococcal disease globally. In the Northern Territory of Australia, a unique government-funded vaccination schedule for Indigenous Australian adults comprising multiple lifetime...
5.
Moberley S, Licciardi P, Balloch A, Andrews R, Leach A, Kirkwood M, et al.
Vaccine
. 2017 Apr;
35(22):2908-2915.
PMID: 28455171
Background: Indigenous adults residing in the Northern Territory of Australia experience elevated rates of invasive pneumococcal disease despite the routine use of 23-valent pneumococcal polysaccharide vaccine (23vPPV). We hypothesised that...
6.
McCarthy E, Subramaniam H, Prust M, Prescott M, Mpasela F, Mwango A, et al.
PLoS One
. 2017 Apr;
12(4):e0175534.
PMID: 28419106
Introduction: In urban areas, crowded HIV treatment facilities with long patient wait times can deter patients from attending their clinical appointments and picking up their medications, ultimately disrupting patient care...
7.
Wang P, Mwango A, Moberley S, Brockman B, Connor A, Kalesha-Masumbu P, et al.
PLoS One
. 2015 Oct;
10(10):e0141455.
PMID: 26513240
Background: We assessed the integration of early infant HIV diagnosis with the expanded programme for immunization in a rural Zambian setting with the aim of determining whether infant and postpartum...
8.
Cashman P, Moberley S, Dalton C, Stephenson J, Elvidge E, Butler M, et al.
Vaccine
. 2014 Aug;
32(42):5503-8.
PMID: 25077424
Vaxtracker is a web based survey for active post marketing surveillance of Adverse Events Following Immunisation. It is designed to efficiently monitor vaccine safety of new vaccines by early signal...
9.
Quinn H, Wood N, Cannings K, Dey A, Wang H, Menzies R, et al.
Pediatr Infect Dis J
. 2014 Apr;
33(9):959-65.
PMID: 24751862
Background: Surveillance for intussusception (IS) has been recommended in countries using rotavirus vaccine, but can be resource intensive. There is little data about the relative severity of rotavirus vaccine-associated IS...
10.
Moberley S, Holden J, Tatham D, Andrews R
Cochrane Database Syst Rev
. 2013 Feb;
(1):CD000422.
PMID: 23440780
Background: Diseases caused by Streptococcus pneumoniae (S. pneumoniae) continue to cause substantial morbidity and mortality globally. Whilst pneumococcal polysaccharide vaccines (PPVs) have the potential to prevent disease and death, the...